Variables | PSA (ng/ml) | Sample | Pourcentage | Death | |
| Average (extreme) | (n = 51) | (%) | n (%) | |
Age (year) Average |
| 69.4 ± 9.7 (40 - 92) |
|
| |
<60 years |
| 7 | 13.7 | - | |
60 - 69 years |
| 17 | 33.3 | - | |
70 - 79 years |
| 20 | 39.2 | - | |
≥80 years |
| 7 | 13.7 | - | |
Symptoms |
|
|
|
| |
Obstructive signs |
| 37 | 72.5 | - | |
Irritative signs |
| 17 | 33.3 | - | |
Haematuria |
| 4 | 7.8 | - | |
Medical history |
|
|
|
| |
Arterial hypertension |
| 13 | 25.5 | - | |
Diabetes PSA Stage of diagnosis Metastatic cancer High-risk cancer Medium risk cancer Low-risk cancer Metastasis locations Bones Nods Testis Multiples Annual frequency and death 2014 2015 2016 2017 General survival in 4 years |
51, 5 (34.3- ≥100, 0)
| 6 51
24 13 10 4 n (24) 12 4 3 5
19 6 14 12 41 | 11.8 100
47.1 25.5 19.6 7.8 47.1 50.0 16.7 12.5 20.8
37.2 11.7 27.4 23.5 80.4 | - -
- - - - - - - - - 10 (19.6)* 1 (5.2) 2 (33.3) 1 (7.1) 6 (50) - |